(Q54747119)

3 June 2018

title

Inhibition of soluble CD4 therapy by antibodies to HIV. (English)

1 reference

3 June 2018

author name string

L N Callahan

series ordinal

1

1 reference

3 June 2018

M A Norcross

series ordinal

2

1 reference

3 June 2018

language of work or name

English

0 references

publication date

1 September 1989

1 reference

3 June 2018

published in

The Lancet

1 reference

3 June 2018

volume

2

1 reference

3 June 2018

page(s)

734-735

1 reference

3 June 2018

issue

8665

1 reference

3 June 2018

Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990790-3

7 January 2021

HIV infection is blocked in vitro by recombinant soluble CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990790-3

7 January 2021

A soluble CD4 protein selectively inhibits HIV replication and syncytium formation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990790-3

7 January 2021

A soluble form of CD4 (T4) protein inhibits AIDS virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990790-3

7 January 2021

Soluble CD4 molecules neutralize human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990790-3

7 January 2021

Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas exotoxin hybrid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990790-3

7 January 2021

A specific assay measuring binding of 125I-Gp 120 from HIV to T4+/CD4+ cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2990790-3

7 January 2021

10.1016/S0140-6736(89)90790-3

Identifiers

DOI

1 reference

3 June 2018

PubMed ID

2570974

1 reference

3 June 2018